Skip to main content

Post-IPO Equity Pharmaceutical Companies

Explore 203 pharmaceutical startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
203
Total Funding
$2.9B
Avg Funding
$115.9M
Cities
21

Export 203 Post-IPO Equity Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Sydney, Australia
$132.4M
raised

Clarity Pharmaceuticals is a personalized medicine company focused on the treatment of serious disease.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Würzburg, Germany
$23.2M
raised

Pentixapharm develop PentixaFor and PentixaTher as a theranostic radiopharmaceutical pair.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$60.0M
raised

Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$100.0M
raised

Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$15.0M
raised

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 203 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Fort Lauderdale, United States
$100K
raised

Psycheceutical is a patented delivery technology that provides safe bioavailable psychedelic pharmaceutical medicines.

Jul 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$12.0M
raised

Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.

Jul 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$375.1M
raised

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$25.0M
raised

Clever Leaves is a multi-national operator (MNO) and a licensed producer of pharmaceutical-grade medical cannabis.

Jul 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Redwood City, United States
$132.0M
raised

Jasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 203 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Bethesda, United States
$7.0M
raised

Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Washington, United States
$5.0M
raised

60 Degrees Pharmaceuticals develops and commercializes new medicines to treat and prevent infectious diseases.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Del Mar, United States
$30.0M
raised

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Jul 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$632.5M
raised

Erasca is a developer of oncology drugs intended to provide precision oncology options.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$1.0B
raised

BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 203 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Englewood Cliffs, United States
$11.7M
raised

Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$175.0M
raised

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Markham, Canada
$5.0M
raised

1CM vision is to be the leading cannabis company globally with solutions that add value to consumers and companies.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Gothenburg, Sweden
$1.6M
raised

Alzinova operates as a biotechnology company engaged in drug discovery research for Alzheimer’s disease.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$50.0M
raised

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 203 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Bromma, Sweden
$1.6M
raised

OncoZenge develops better products for the supportive care of cancer patients.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Uppsala, Sweden
$22.4M
raised

Dicot Pharma, focused on drug discovery and development of a modern potency drug treating erectile dysfunction better than existing drugs.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Wilmington, United States
$22.3M
raised

NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$50.0M
raised

Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Woburn, United States
$8.5M
raised

Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 26 to 50 of 203 companies

Ready to Connect with Post-IPO Equity Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 203 post-ipo equity pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked